The AID study: protocol for a randomised controlled trial of intrauterine insemination in the natural cycle compared with intracervical insemination in the natural cycle.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
23 07 2019
Historique:
entrez: 26 7 2019
pubmed: 26 7 2019
medline: 7 7 2020
Statut: epublish

Résumé

At present, studies comparing intrauterine insemination in the natural cycle versus intracervical insemination in the natural cycle in women undergoing artificial insemination with donor sperm are scarce. We perform a randomised controlled non-inferiority trial among five secondary and tertiary fertility clinics in the Netherlands and one tertiary fertility clinic in Belgium. Women eligible for artificial insemination with donor sperm are included. We perform six cycles of artificial insemination with donor sperm within a time horizon of 8 months comparing intrauterine insemination in the natural cycle with intracervical insemination in the natural cycle. The primary outcome is ongoing pregnancy leading to live birth conceived within eight months after randomisation. Secondary outcomes are clinical pregnancy rate, miscarriage rate, multiple pregnancy rate, pregnancy complications (preterm birth, birth weight <2500 g, pregnancy induced hypertension, (pre-) eclampsia, Hemolysis Elevated Liver enzymes Low Platelets (HELLP)), time to ongoing pregnancy, direct and indirect costs. To demonstrate the non-inferiority of intracervical insemination with a margin of 12%, we need 208 women per arm. The study has been approved by the Medical Ethical Committee of the Academic Medical Centre and from the Dutch Central Committee on research involving human subjects (47330-018-13). The boards of the participating hospitals approved the study. Results will be disseminated through peer-reviewed publications and presentations at international scientific meetings. NTR4462.

Identifiants

pubmed: 31340957
pii: bmjopen-2018-026065
doi: 10.1136/bmjopen-2018-026065
pmc: PMC6661593
doi:

Banques de données

NTR
['NTR4462']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e026065

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: No, there are no competing interests for any author.

Références

Fertil Steril. 2013 Jan;99(1):47-62
pubmed: 23095142
Hum Reprod. 2004 Mar;19(3):490-503
pubmed: 14998942
Lancet. 2005 Aug 6-12;366(9484):452-3; author reply 453-4
pubmed: 16084249
Hum Reprod. 2014 Apr;29(4):697-703
pubmed: 24549212
Lancet. 2005 May 21-27;365(9473):1807-16
pubmed: 15910954
Cochrane Database Syst Rev. 2018 Jan 25;1:CD000317
pubmed: 29368795
Hum Reprod. 2015 Mar;30(3):603-7
pubmed: 25637621

Auteurs

Petronella Kop (P)

Center for Reproductive Medicine, Amsterdam Reproduction & Development Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands p.a.kop@amc.uva.nl.

Madelon van Wely (M)

Center for Reproductive Medicine, Amsterdam Reproduction & Development Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

Annemiek Nap (A)

Department of Gynaecology and Obstetrics, Rijnstate, Arnhem, Gelderland, Netherlands.

Ben Willem Mol (BW)

Department of Obstetrics and gynaecology, Monash University Central Clinical School, Melbourne, Victoria, Australia.

Rob Bernardus (R)

Fertility clinic, Nij Barrahus, Wolvega, Netherlands.

Michael De Brucker (M)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussel, Belgium.

Pim Janssens (P)

Clinical Chemistry and Haematology, Hospital Rijnstate, Arnhem, Gelderland, Netherlands.

Ben Cohlen (B)

Obstetrics and Gynaecology, Isala Hospitals, Zwolle, Overijssel, Netherlands.

Jacqueline Pieters (J)

Fertility clinic, Vivaneo Medisch Centrum Kinderwens, Leiderdorp, Netherlands.

Sjoerd Repping (S)

Center for Reproductive Medicine, Amsterdam Reproduction & Development Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

Fulco van der Veen (F)

Center for Reproductive Medicine, Amsterdam Reproduction & Development Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

Monique H Mochtar (MH)

Center for Reproductive Medicine, Amsterdam Reproduction & Development Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH